Risk of cancer inpatients with scleroderma: A population based cohort study

Annals of the Rheumatic Diseases

Volumn 62, Issue 8, 2003, Pages 728-731

  Hill, C L ^a   Nguyen, A M ^b   Roder, D ^c   Roberts Thomson, P ^d  

^a QUEEN ELIZABETH HOSPITAL   (Australia)

^b DEPARTMENT OF HUMAN SERVICES   (Australia)

^c Anti Cancer Foundation   (Australia)

^d FLINDERS MEDICAL CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BLADDER CANCER; BREAST CANCER; CANCER; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER REGISTRY; CANCER RISK; COHORT ANALYSIS; DIGESTIVE SYSTEM CANCER; DISEASE ASSOCIATION; FEMALE; HEMATOPOIETIC SYSTEM TUMOR; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; POPULATION RISK; PRIORITY JOURNAL; PROSTATE CANCER; SCLERODERMA; SEX DIFFERENCE; ADOLESCENT; AGED; AUSTRALIA; INCIDENCE; LOCALIZED SCLERODERMA; LUNG TUMOR; MIDDLE AGED; NEOPLASM; REGISTER; RISK FACTOR; SYSTEMIC SCLEROSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; FEMALE; HUMANS; INCIDENCE; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASMS; REGISTRIES; RISK FACTORS; SCLERODERMA, LOCALIZED; SCLERODERMA, SYSTEMIC; SOUTH AUSTRALIA;

EID: 0037821181     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.62.8.728     Document Type: Article

References (23)

1. Roumm AD, Medsger TA Jr. Cancer and systemic sclerosis. Arthritis Rheum 1985;28:1336-40.
2. Abu-Shakra M, Guillemin F, Lee P. Cancer in systemic sclerosis. Arthritis Rheum 1993;36:460-4.
3. Rosenthal AK, McLaughlin JK, Gridley G, Nyren O. Incidence of cancer among patients with systemic sclerosis. Cancer 1995;76:910-14.
4. Rosenthal AK, McLaughlin JK, Liner MS, Persson I. Scleroderma and malignancy: an epidemiological study. Ann Rheum Dis 1993;52:531-3.
5. Yang Y, Fujita J, Tokuda M, Bandoh S, Ishida T. Lung cancer associated with several connective tissue diseases: with a review of literature. Rheumatol Int 2001;21:106-11.
6. Chatterjee S, Severson RK, Weiss LK, Kau T, Mayes MD. Risk of malignancy in scleroderma [abstract]. Arthritis Rheum 2000;43{suppl):S1490.
7. Roberts-Thomson PJ, Jones M, Hakendorf P, Kencana Dharmapatni AASS, Walker JG, MacFarlane JG, et al. Scleroderma in South Australia: epidemiological observations of possible pathogenic significance. Int Med J 2001;31:220-9.
8. Masi MT, Rodnan GP, Medsger Jr TA, Altman RD, D'Angelo WA, Fries JF et al. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980;23:581-90.
9. Englert H, Small-McMahon J, Davis K, O'Connor H, Chambers P, Brooks P. Systemic sclerosis prevalence and mortality in Sydney 1974-88. Aust NZ J Med 1999;29:42-50.
10. LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr, et al. Scleroderma: classification, subset and pathogenesis. J Rheumatol 1988;25:688-94.
11. Bonett A, Roder D, Milliken L. The South Australian Cancer Registry: a means of assessing cancer incidence, mortality and case survival. Eur J Cancer 1992;28A:1923-6.
12. Mayes MD. The establishment and utility of a population-based registry to understand the epidemiology of systemic sclerosis. Curr Rheumatol Rep 2000;2:512-16.
13. Chandran G, Smith M, Ahern MJ, Roberts-Thomson PJ. A study of scleroderma in South Australia: prevalence, subset characteristics and nailfold capillaroscopy. Aust NZ J Med 1995;25:688-94.
14. Hassett C, Harnett P, Manolios N. Scleroderma in association with the use of docetaxel (taxotere) for breast cancer. Clin Exp Rheumatol 2001;19:197-200.
15. Duncan SC, Winkelmann RK. Cancer and scleroderma. Arch Dermatol 1979;115:950-5.
16. Forbes AM, Woodrow JC, Verbov JL, Graham RM. Carcinoma of breast and scleroderma: four further cases and a literature review. Br J Rheumatol 1989;28:65-9.
17. Wenzel J. Scleroderma and malignancy. Mechanisms of interrelationship. Eur J Dermatol 2002;12:296-300.
18. Ma Y, Seneviratne CK, Koss M. Idiopathic pulmonary fibrosis and malignancy. Curr Opin Pulm Med 2001;7:278-82.
19. Emerit I, Levy A, Housset E. Sclerodermie généraliséé et cassures chromosomiques. Mise en évidence d'un "facteur cassant" dans la serum des maladies. [Generalized scleroderma and chromosome breakage. Demonstration of a breaking factor in patients serum.] Ann Genet 1973;16:135-8.
20. Rittner G, Schwanitz G, Baur MP, Black CM, Welsh KI, Kuhnl P, et al. Family studies in sderoderma (systemic sclerosis) demonstrating an HLA-linked increased chromosomal breakage rate in cultured lymphocytes. Hum Genet 1988;81:64-70.
21. Artlett CM, Black CM, Briggs DC, Stephens C, Welsh KI. DNA allelic alterations within VNTR loci of scleroderma Families. Br J Rheumatol 1996;35:1216-22.
22. Tisi GM, Sabiston DC. Neoplasms of the lung. In: Wintrobe MM, et al, eds. Harrison's principles of internal medicine. New York: McGraw-Hill, 1970:1339-43.
23. Hill CL, Zhang Y, Sigurgeirsson B, Pukkala E, Mellemkjaer L, Airio A, et al. Frequency of specific cancer types in dermatomyositis and polymyositis: combined population data from three Nordic countries. Lancet 2001;357:96-100.